Lavender for Depression

Verdict: Weak, industry-funded signal for depression

Standardized oral lavender oil (Silexan) shows a small, fairly consistent positive signal for mild-to-moderate depression, but the evidence base is thin and entirely manufacturer-funded, so it is not an established treatment and should not replace antidepressants or psychotherapy.

C 🟠 C Weak Evidence Taiwan Regulatory Restriction

🔬Why this grade7-layer evidence engine

The grade reflects a genuine but fragile signal. Only one dedicated mild-to-moderate major-depression RCT exists (PMID 38558147, n=498), where 80 mg/day Silexan beat placebo by just 2.17 MADRS points, a statistically significant but modest effect. The rest of the support comes from anxiety trials, including a mixed anxiety-depression RCT (PMID 26718792, n=318) and a meta-analysis of depressive symptoms pooled from anxiety studies (PMID 35262795), where depression was a secondary or post-hoc endpoint rather than the primary target.

Two structural weaknesses cap the evidence at weak. Every trial was funded by the manufacturer (Dr. Willmar Schwabe GmbH) with multiple author conflicts of interest, and much of the depression signal may simply reflect Silexan's established anxiety effect spilling over rather than an independent antidepressant action. There is no Cochrane-grade synthesis and no replication by independent teams.

Regulators and clinics do not endorse it for depression. The FDA lists lavender oil only as a GRAS flavoring agent, and the WHO and NCCIH treat the depression evidence as preliminary; the American Psychiatric Association and ADAA say nothing about lavender, pointing patients instead to medication, psychotherapy, TMS, or ECT. A theoretical interaction with sedatives adds further caution.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.55
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Taiwan Regulatory Restriction
Confidence
47%
Conflicting evidence
Evidence level
E3
Single high-quality meta-analysis

How strongly each layer supports this effect

lower = less supportive
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
L5 Clinical bodiesAuthoritative stance
0.55
L2 PubMedPrimary literature
0.60
L3 MechanismPlausibility
0.65
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.551
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 無高階證據可裁決
  4. tier_strict_requirement_check — | B→C 因 scope.conflation_risk=true 且 L11 獨評較低 (B7-2 tier cap)
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (3)L2 · primary research & systematic reviews

Lavender oil preparation Silexan is effective in mild-to-moderate major depression: a randomized, placebo- and reference-controlled trial
PMID: 38558147 2025 RCT (double-blind) n = 498
Finding: Silexan superior to placebo with 2.17-point MADRS reduction advantage (p<0.01); also reduced functional impairment on Sheehan Disability Scale.
🟢 High quality ⚠️ Industry-funded Effect size: MD 2.17 points (MADRS) vs placebo
View on PubMed
Efficacy of Silexan in mixed anxiety-depression -- A randomized, placebo-controlled trial
PMID: 26718792 2016 RCT (double-blind) n = 318
Finding: MADRS decreased 9.2 points (Silexan) vs 6.1 (placebo), p<0.001; HAMA also superior (p<0.01).
⚠️ Industry-funded Effect size: MD ~3.1 points (MADRS) vs placebo
View on PubMed
Beneficial effects of Silexan on co-occurring depressive symptoms in patients with subthreshold anxiety and anxiety disorders: randomized, placebo-controlled trials revisited
PMID: 35262795 2023 統合分析
Finding: Silexan superior to placebo for depressed mood (p=0.01) and total depression scores (p<0.01); effect larger in patients depressed at baseline.
⚠️ Industry-funded
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
LAVENDER, OIL (LAVANDULA OFFICINALIS CHAIX) source↗
L4e WHO
Supportive
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬3 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-depression-INT-lavender-001 繁體中文版 →